glp-1 and liver disease GLP-1s are back in the news — but this is a conversation we've explored on our channel before. From weight loss to heart, kidney, liver, sleep metabolic health, the science is SGLT-2 inhibitors and GLP-1 receptor
Description
We assess what's actually going onnot guess
Cited violations included sameness claims equating compounded products with approved brands and trademarked marketing that obscured the actual compounding source and responsibilities
What next when metformin isn't enough for type 2 diabetes
With over a decade of post-marketing surveillance data, the long-term risk profile is better characterized than any other GLP-1 agonist
S2CID 24870292
